Abstract:Diabetes is a serious public health problem. Improvements in the treatment of noncardiac complications from diabetes have resulted in heart disease becoming a leading cause of death in diabetic patients. Several cardiovascular pathological consequences of diabetes such as hypertension affect the heart to varying degrees. However, hyperglycemia, as an independent risk factor, directly causes cardiac damage and leads to diabetic cardiomyopathy. Diabetic cardiomyopathy can occur independent of vascular disease, although the mechanisms are largely unknown. Previous studies have paid little attention to the direct effects of hyperglycemia on cardiac myocytes, and most studies, especially in vitro, have mainly focused on the molecular mechanisms underlying pathogenic alterations in vascular smooth-muscle cells and endothelial cells. Thus, a comprehensive understanding of the mechanisms of diabetic cardiomyopathy is urgently needed to develop approaches for the prevention and treatment of diabetic cardiac complications. This review provides a survey of current understanding of diabetic cardiomyopathy. Current consensus is that hyperglycemia results in the production of reactive oxygen and nitrogen species, which leads to oxidative myocardial injury. Alterations in myocardial structure and function occur in the late stage of diabetes. These chronic alterations are believed to result from acute cardiac responses to suddenly increased glucose levels at the early stage of diabetes. Oxidative stress, induced by reactive oxygen and nitrogen species derived from hyperglycemia, causes abnormal gene expression, altered signal transduction, and the activation of pathways leading to programmed myocardial cell deaths. The resulting myocardial cell loss thus plays a critical role in the development of diabetic cardiomyopathy. Advances in the application of various strategies for targeting the prevention of hyperglycemia-induced oxidative myocardial injury may be fruitful.

Pathological Roles of Oxidative Stress in Cardiac Microvascular Injury

Pathological Roles of Mitochondrial Oxidative Stress and Mitochondrial Dynamics in Cardiac Microvascular Ischemia/Reperfusion Injury

Systematic Understanding of Pathophysiological Mechanisms of Oxidative Stress-Related Conditions—Diabetes Mellitus, Cardiovascular Diseases, and Ischemia–Reperfusion Injury

Oxidative Stress and MicroRNAs in Endothelial Cells under Metabolic Disorders

Reactive Oxygen Species and Oxidative Stress in Vascular-Related Diseases

Mitochondrial Stress as a Central Player in the Pathogenesis of Hypoxia-Related Myocardial Dysfunction: New Insights

Disulfide stress and its role in cardiovascular diseases

Role of Iron-Related Oxidative Stress and Mitochondrial Dysfunction in Cardiovascular Diseases

Brain Oxidative Stress Contributing to Pathogenesis of Cardiovascular Diseases

Oxidative Stress and Diabetic Cardiomyopathy: A Brief Review

Oxidative stress disrupts vascular microenvironmental homeostasis affecting the development of atherosclerosis

Redox Roles of Reactive Oxygen Species in Cardiovascular Diseases

Oxidative stress and stress signaling: menace of diabetic cardiomyopathy

Discovery of new therapeutic redox targets for cardioprotection against ischemia/reperfusion injury and heart failure

Role of Oxidative Stress in Diabetic Cardiomyopathy

Mechanical stress induced mitochondrial dysfunction in cardiovascular diseases: Novel mechanisms and therapeutic targets

Antioxidant Therapeutic Strategies for Cardiovascular Conditions Associated with Oxidative Stress

Histone Methylation and Oxidative Stress in Cardiovascular Diseases.

Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease – an overview

Role of Oxidative Stress in Reperfusion following Myocardial Ischemia and Its Treatments